OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism

NCT01889134 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Primary Hyperparathyroidism

Interventions

DRUG: Sedron (alendronate)
PROCEDURE: Parathyroidectomy

Sponsor

Wroclaw Medical University

Collaborators

[object Object]